Rezolute (RZLT) Preferred Dividend Payments (2016 - 2019)
Rezolute's (RZLT) quarterly Preferred Dividend Payments came in at $2.2 million in Q1 2019, down 62.24% quarter-over-quarter from $5.9 million in Q2 2016.
Rezolute (RZLT) Preferred Dividend Payments (2016 - 2019) Analysis & Trends
Rezolute has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $2.2 million for Q1 2019.
- Preferred Dividend Payments for Q1 2019 came in at $2.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2019 was $8.1 million (changed N/A YoY), and the FY2016 annual result was $6.0 million, changed N/A from the prior year.
- Preferred Dividend Payments came in at $2.2 million for Q1 2019 at Rezolute, down from $5.9 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $5.9 million in Q2 2016 to a low of $61279.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 2.23 Mn |
| Jun 30, 2016 | 5.91 Mn |
| Mar 31, 2016 | 61,279.00 |